Sign in

CIK 0001368514

  • Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562590442
Phone
+1 201-478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Open-market buy Director bought 45,769 shares at $6.50 ($297,499)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Director bought 4,000 shares at $8.48 ($33,918)
  12. 4 Open-market buy President & CEO bought 6,400 shares at $8.47 ($54,224)
  13. 4 Open-market buy Director bought 500 shares at $9.01 ($4,503)
  14. 4 Open-market buy President & CEO bought 500 shares at an average $9.00 ($4,501)
  15. 4 Open-market buy Director bought 6,000 shares at $9.16 ($54,961)
  16. 4 Open-market buy President & CEO bought 2,250 shares at an average $9.15 ($20,584)
  17. 4 Open-market buy President & CEO bought 1,800 shares at $9.17 ($16,513)
  18. 4 Open-market buy Chief Financial Officer bought 1,000 shares at an average $9.15 ($9,151)
  19. 4 Open-market buy President & CEO bought 1,800 shares at $9.18 ($16,529)
  20. 4 Open-market buy President & CEO bought 3,861 shares at an average $9.21 ($35,572)

Page 14 of 19 · 364 filings